Filter News
Area of Research
- (-) Neutron Science (4)
- Advanced Manufacturing (4)
- Biology and Environment (65)
- Biology and Soft Matter (1)
- Building Technologies (1)
- Clean Energy (57)
- Computational Biology (2)
- Computational Engineering (2)
- Computer Science (1)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion and Fission (4)
- Isotopes (3)
- Materials (14)
- Materials for Computing (7)
- Mathematics (1)
- National Security (18)
- Supercomputing (29)
News Topics
- (-) Biomedical (2)
- (-) Cybersecurity (1)
- (-) Environment (1)
- (-) Frontier (1)
- 3-D Printing/Advanced Manufacturing (1)
- Artificial Intelligence (4)
- Biology (4)
- Chemical Sciences (1)
- Computer Science (5)
- Coronavirus (2)
- Decarbonization (1)
- Energy Storage (2)
- Fusion (1)
- High-Performance Computing (1)
- Materials (6)
- Materials Science (7)
- Microscopy (1)
- Nanotechnology (2)
- National Security (1)
- Neutron Science (24)
- Physics (2)
- Quantum Computing (1)
- Quantum Science (3)
- Security (1)
- Space Exploration (2)
- Summit (1)
- Transportation (1)
Media Contacts
Paul Langan will join ORNL in the spring as associate laboratory director for the Biological and Environmental Systems Science Directorate.
Three ORNL scientists have been elected fellows of the American Association for the Advancement of Science, or AAAS, the world’s largest general scientific society and publisher of the Science family of journals.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.